These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A study of sirolimus and mTOR kinase inhibitor in a hypomorphic Holditch SJ; Brown CN; Atwood DJ; Lombardi AM; Nguyen KN; Toll HW; Hopp K; Edelstein CL Am J Physiol Renal Physiol; 2019 Jul; 317(1):F187-F196. PubMed ID: 31042058 [TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase 3beta is a novel regulator of high glucose- and high insulin-induced extracellular matrix protein synthesis in renal proximal tubular epithelial cells. Mariappan MM; Shetty M; Sataranatarajan K; Choudhury GG; Kasinath BS J Biol Chem; 2008 Nov; 283(45):30566-75. PubMed ID: 18701453 [TBL] [Abstract][Full Text] [Related]
6. The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway. Hartman TR; Liu D; Zilfou JT; Robb V; Morrison T; Watnick T; Henske EP Hum Mol Genet; 2009 Jan; 18(1):151-63. PubMed ID: 18845692 [TBL] [Abstract][Full Text] [Related]
7. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Tee AR; Fingar DC; Manning BD; Kwiatkowski DJ; Cantley LC; Blenis J Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13571-6. PubMed ID: 12271141 [TBL] [Abstract][Full Text] [Related]
8. Transforming Growth Factor β1-induced Apoptosis in Podocytes via the Extracellular Signal-regulated Kinase-Mammalian Target of Rapamycin Complex 1-NADPH Oxidase 4 Axis. Das R; Xu S; Nguyen TT; Quan X; Choi SK; Kim SJ; Lee EY; Cha SK; Park KS J Biol Chem; 2015 Dec; 290(52):30830-42. PubMed ID: 26565025 [TBL] [Abstract][Full Text] [Related]
9. RhoE inhibits 4E-BP1 phosphorylation and eIF4E function impairing cap-dependent translation. Villalonga P; Fernández de Mattos S; Ridley AJ J Biol Chem; 2009 Dec; 284(51):35287-96. PubMed ID: 19850923 [TBL] [Abstract][Full Text] [Related]
10. Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin. Tee AR; Anjum R; Blenis J J Biol Chem; 2003 Sep; 278(39):37288-96. PubMed ID: 12867426 [TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease. Chen L; Zhou X; Fan LX; Yao Y; Swenson-Fields KI; Gadjeva M; Wallace DP; Peters DJ; Yu A; Grantham JJ; Li X J Clin Invest; 2015 Jun; 125(6):2399-412. PubMed ID: 25961459 [TBL] [Abstract][Full Text] [Related]
12. c-myc Repression of TSC2 contributes to control of translation initiation and Myc-induced transformation. Ravitz MJ; Chen L; Lynch M; Schmidt EV Cancer Res; 2007 Dec; 67(23):11209-17. PubMed ID: 18056446 [TBL] [Abstract][Full Text] [Related]
13. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells. de Stephanis L; Bonon A; Varani K; Lanza G; Gafà R; Pinton P; Pema M; Somlo S; Boletta A; Aguiari G Clin Exp Nephrol; 2017 Apr; 21(2):203-211. PubMed ID: 27278932 [TBL] [Abstract][Full Text] [Related]
14. Berberine slows cell growth in autosomal dominant polycystic kidney disease cells. Bonon A; Mangolini A; Pinton P; Del Senno L; Aguiari G Biochem Biophys Res Commun; 2013 Nov; 441(3):668-74. PubMed ID: 24184483 [TBL] [Abstract][Full Text] [Related]
15. TSC2 mediates cellular energy response to control cell growth and survival. Inoki K; Zhu T; Guan KL Cell; 2003 Nov; 115(5):577-90. PubMed ID: 14651849 [TBL] [Abstract][Full Text] [Related]
16. Deregulation of mTOR signaling is involved in thymic lymphoma development in Atm-/- mice. Kuang X; Shen J; Wong PK; Yan M Biochem Biophys Res Commun; 2009 Jun; 383(3):368-72. PubMed ID: 19364503 [TBL] [Abstract][Full Text] [Related]
17. Nephrocystin-1 forms a complex with polycystin-1 via a polyproline motif/SH3 domain interaction and regulates the apoptotic response in mammals. Wodarczyk C; Distefano G; Rowe I; Gaetani M; Bricoli B; Muorah M; Spitaleri A; Mannella V; Ricchiuto P; Pema M; Castelli M; Casanova AE; Mollica L; Banzi M; Boca M; Antignac C; Saunier S; Musco G; Boletta A PLoS One; 2010 Sep; 5(9):e12719. PubMed ID: 20856870 [TBL] [Abstract][Full Text] [Related]
18. Protein kinase C-delta and phosphatidylinositol 3-kinase/Akt activate mammalian target of rapamycin to modulate NF-kappaB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells. Minhajuddin M; Bijli KM; Fazal F; Sassano A; Nakayama KI; Hay N; Platanias LC; Rahman A J Biol Chem; 2009 Feb; 284(7):4052-61. PubMed ID: 19074768 [TBL] [Abstract][Full Text] [Related]
19. The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses. Smith EM; Finn SG; Tee AR; Browne GJ; Proud CG J Biol Chem; 2005 May; 280(19):18717-27. PubMed ID: 15772076 [TBL] [Abstract][Full Text] [Related]
20. p53/TAp63 and AKT regulate mammalian target of rapamycin complex 1 (mTORC1) signaling through two independent parallel pathways in the presence of DNA damage. Cam M; Bid HK; Xiao L; Zambetti GP; Houghton PJ; Cam H J Biol Chem; 2014 Feb; 289(7):4083-94. PubMed ID: 24366874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]